| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2873094 | The Annals of Thoracic Surgery | 2013 | 7 Pages |
Abstract
EBUS-TBNA performed with the patient under moderate sedation can be expected to yield sufficient tissue for sequential molecular analysis in the majority of patients. In an era of targeted therapy for lung adenocarcinomas, EBUS-TBNA is effective in clinical practice for complete diagnosis, staging, and treatment planning in these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Julissa MD, Anjali MD, MBA, Roger MD, Alexis BS, Matt MSE, Matthew MD, Lyall MD, Frank MD, Mark E. MD, Joshua MD, William MD,